Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Italy · Delayed Price · Currency is EUR

47.48

-0.34 (-0.71%)

At close: Feb 11, 2026

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Italy Revenue	339.11M	336.26M	317.14M
Italy Revenue Growth	0.85%	6.03%	14.36%
International Revenue	2.14B	2.01B	1.77B
International Revenue Growth	6.75%	13.60%	12.01%

Revenue by Geography 2

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Europe Revenue	1.65B	1.49B
Europe Revenue Growth	10.59%	9.59%
Asia and Oceania Revenue	156.01M	139.88M
Asia and Oceania Revenue Growth	11.53%	21.70%
America Revenue	477.46M	394.86M
America Revenue Growth	20.92%	22.06%
Africa Revenue	58.03M	55.52M
Africa Revenue Growth	4.52%	3.96%

Revenue Breakdown

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Specialty & Primary Care Revenue	1.53B	1.51B	1.37B
Specialty & Primary Care Revenue Growth	1.44%	10.24%	8.75%
Rare Diseases Revenue	950.29M	833.86M	714.72M
Rare Diseases Revenue Growth	13.96%	16.67%	19.96%

Revenue Breakdown 2

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Cardiovascular Revenue	399.15M	385.21M	365.21M
Cardiovascular Revenue Growth	3.62%	5.47%	3.80%
Urology and Uro-Oncology Revenue	404.56M	399.94M	280.38M
Urology and Uro-Oncology Revenue Growth	1.15%	42.64%	23.27%
Gastrointestinal Revenue	226.95M	217.50M	219.27M
Gastrointestinal Revenue Growth	4.35%	-0.81%	7.90%
Cough and Cold Revenue	129.52M	137.28M	137.12M
Cough and Cold Revenue Growth	-5.65%	0.12%	9.25%
Other Treatment Areas Revenue	308.65M	309.31M	311.60M
Other Treatment Areas Revenue Growth	-0.21%	-0.74%	3.65%
Pharmaceutical Chemicals Revenue	60.62M	58.47M	54.03M
Pharmaceutical Chemicals Revenue Growth	3.68%	8.21%	10.55%
Hema-Oncology Revenue	336.71M	253.23M	200.85M
Hema-Oncology Revenue Growth	32.97%	26.08%	47.72%
Endocrinology Revenue	347.03M	321.69M	242.32M
Endocrinology Revenue Growth	7.88%	32.75%	40.96%
Metabolic and Other Areas Revenue	266.55M	258.94M	271.55M
Metabolic and Other Areas Revenue Growth	2.94%	-4.64%	-5.68%

Revenue Breakdown 3

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Pharmaceutical Chemicals Revenue	60.62M	58.47M	54.03M
Pharmaceutical Chemicals Revenue Growth	3.68%	8.21%	10.55%

EBITDA

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Specialty & Primary Care EBITDA	516.45M	524.44M	467.27M
Specialty & Primary Care EBITDA Growth	-1.52%	12.23%	11.86%
Rare Diseases EBITDA	392.73M	341.33M	302.36M
Rare Diseases EBITDA Growth	15.06%	12.89%	18.56%

EBIT

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Specialty & Primary Care Operating Income	404.03M	426.73M	388.24M
Specialty & Primary Care Operating Income Growth	-5.32%	9.92%	24.51%
Rare Diseases Operating Income	227.32M	212.13M	169.77M
Rare Diseases Operating Income Growth	7.16%	24.95%	35.25%

Key Performance Indicators

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Specialty & Primary Care Like-For-Like Growth	5.70%	13.60%
Rare Diseases Like-For-Like Growth	15.70%	14.90%
Total Like-For-Like Growth	9.20%	14.00%

Updated Jun 30, 2025. Data Source: Fiscal.ai.